ArticleJournal for immunotherapy of cancer2018

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy.

Michael Lattanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.